Interpace Biosciences, Inc. (IDXG)

2.12 +0.14 (+7.07%) USD  |  OTCM  |  May 01, 15:24
More

Interpace Biosciences Cash and Short Term Investments (Annual) : 2.505M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for IDXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
FONAR Corp. 56.45M
Thermo Fisher Scientific, Inc. 10.11B
XWELL, Inc. 2.624M
Hypha Labs, Inc. 0.0381M
Veracyte, Inc. 412.89M